Inhibition of DNA methylation attenuates low-dose cadmium-induced cardiac contractile and intracellular Ca2+ anomalies

Clinical and Experimental Pharmacology and Physiology

Volumn 40, Issue 10, 2013, Pages 706-712

  Turdi, Subat ^a   Sun, Weixia ^b,c   Tan, Yi ^b   Yang, Xiaohui ^a   Cai, Lu ^b   Ren, Jun ^a  

^a UNIVERSITY OF WYOMING COLLEGE OF HEALTH SCIENCES   (United States)

^b University of Louisville School of Medicine   (United States)

^c THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

Author keywords

Cadmium; Cardiac; Contraction; Intracellular Ca2+

Indexed keywords

CADMIUM; CALCIUM; CASPASE 3; GLUCOSE; INTERCELLULAR ADHESION MOLECULE 1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BODY WEIGHT; CALCIUM CELL LEVEL; CALCIUM HOMEOSTASIS; CONTROLLED STUDY; DNA METHYLATION; ECHOCARDIOGRAPHY; EXPOSURE; FIBROSIS; GLUCOSE BLOOD LEVEL; HEART CONTRACTION; HEART MUSCLE CONTRACTILITY; HEART RATE; HEART VENTRICLE WALL; MALE; MOUSE; NONHUMAN; ORGAN WEIGHT; PROTEIN EXPRESSION; WESTERN BLOTTING;

CADMIUM; CARDIAC; CONTRACTION; INTRACELLULAR CA2+;

ANIMALS; AZACITIDINE; BIOMECHANICAL PHENOMENA; CADMIUM; CALCIUM; CELLS, CULTURED; CYTOKINES; DNA METHYLATION; DRUG ADMINISTRATION SCHEDULE; ENVIRONMENTAL POLLUTANTS; ENZYME INHIBITORS; FEMALE; HEART; MALE; MICE; MICE, INBRED C57BL; MYOCARDIAL CONTRACTION; MYOCARDIUM; RANDOM ALLOCATION;

EID: 84884696964     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/1440-1681.12158     Document Type: Article

References (48)

1. Peters JL, Perlstein TS, Perry MJ, McNeely E, Weuve J. Cadmium exposure in association with history of stroke and heart failure. Environ. Res. 2010; 110: 199-206.
2. Navas-Acien A, Selvin E, Sharrett AR, Calderon-Aranda E, Silbergeld E, Guallar E. Lead, cadmium, smoking, and increased risk of peripheral arterial disease. Circulation 2004; 109: 3196-201.
3. Lee MS, Park SK, Hu H, Lee S. Cadmium exposure and cardiovascular disease in the 2005 Korea National Health and Nutrition Examination Survey. Environ. Res. 2011; 111: 171-6.
4. Liu J, Qu W, Kadiiska MB. Role of oxidative stress in cadmium toxicity and carcinogenesis. Toxicol. Appl. Pharmacol. 2009; 238: 209-14.
5. Wang B, Wang S, Shao C, Wang G, Li Y, Cai L. Proteomic characterization of the late and persistent effects of cadmium at low doses on the rat liver. J. Appl. Toxicol. 2013; 33: 546-57.
6. Wang B, Luo Q, Shao C et al. The late and persistent pathogenic effects of cadmium at very low levels on the kidney of rats. Dose Response 2013; 11: 60-81.
7. Wang B, Li Y, Tan Y et al. Low-dose Cd induces hepatic gene hypermethylation, along with the persistent reduction of cell death and increase of cell proliferation in rats and mice. PLoS ONE 2012; 7: e33853.
8. Nishijo M, Nakagawa H, Morikawa Y et al. Mortality of inhabitants in an area polluted by cadmium: 15 year follow up. Occup. Environ. Med. 1995; 52: 181-4.
9. Tomera JF, Lilford K, Kukulka SP, Friend KD, Harakal C. Divalent cations in hypertension with implications to heart disease: Calcium, cadmium interactions. Methods Find. Exp. Clin. Pharmacol. 1994; 16: 97-107.
10. Carmignani M, Boscolo P. Cardiovascular responsiveness to physiological agonists of male rats made hypertensive by long-term exposure to cadmium. Sci. Total Environ. 1984; 34: 19-33.
11. Zepeda R, Castillo P, Saez D, Llanos MN, Ronco AM. Cardiac tissue injury resistance during myocardial infarction at adulthood by developmental exposure to cadmium. Cardiovasc. Toxicol. 2012; 12: 64-72.
12. Ronco AM, Montenegro M, Castillo P et al. Maternal exposure to cadmium during gestation perturbs the vascular system of the adult rat offspring. Toxicol. Appl. Pharmacol. 2011; 251: 137-45.
13. Tellez-Plaza M, Navas-Acien A, Menke A, Crainiceanu CM, Pastor-Barriuso R, Guallar E. Cadmium exposure and all-cause and cardiovascular mortality in the U.S. general population. Environ. Health Perspect. 2012; 120: 1017-22.
14. Szuster-Ciesielska A, Stachura A, Slotwinska M et al. The inhibitory effect of zinc on cadmium-induced cell apoptosis and reactive oxygen species (ROS) production in cell cultures. Toxicology 2000; 145: 159-71.
15. + exchanger and PKC. Free Radic. Res. 2005; 39: 1059-70.
16. Son YO, Wang L, Poyil P et al. Cadmium induces carcinogenesis in BEAS-2B cells through ROS-dependent activation of PI3K/AKT/GSK-3beta/beta-catenin signaling. Toxicol. Appl. Pharmacol. 2012; 264: 153-60.
17. Ferramola MLPerez Diaz MF, Honore SM et al. Cadmium-induced oxidative stress and histological damage in the myocardium. Effects of a soy-based diet. Toxicol. Appl. Pharmacol. 2012; 265: 380-9.
18. Fujishiro H, Okugaki S, Yasumitsu S, Enomoto S, Himeno S. Involvement of DNA hypermethylation in down-regulation of the zinc transporter ZIP8 in cadmium-resistant metallothionein-null cells. Toxicol. Appl. Pharmacol. 2009; 241: 195-201.
19. Vandegehuchte MB, Kyndt T, Vanholme B, Haegeman A, Gheysen G, Janssen CR. Occurrence of DNA methylation in Daphnia magna and influence of multigeneration Cd exposure. Environ. Int. 2009; 35: 700-6.
20. Jiang G, Xu L, Song S et al. Effects of long-term low-dose cadmium exposure on genomic DNA methylation in human embryo lung fibroblast cells. Toxicology 2008; 244: 49-55.
21. Takiguchi M, Achanzar WE, Qu W, Li G, Waalkes MP. Effects of cadmium on DNA-(cytosine-5) methyltransferase activity and DNA methylation status during cadmium-induced cellular transformation. Exp. Cell Res. 2003; 286: 355-65.
22. Traore A, Ruiz S, Baudrimont I et al. Combined effects of okadaic acid and cadmium on lipid peroxidation and DNA bases modifications (m5dC and 8-(OH)-dG) in Caco-2 cells. Arch. Toxicol. 2000; 74: 79-84.
23. Arita A, Costa M. Epigenetics in metal carcinogenesis: Nickel, arsenic, chromium and cadmium. Metallomics 2009; 1: 222-8.
24. Wang B, Li Y, Shao C, Tan Y, Cai L. Cadmium and its epigenetic effects. Curr. Med. Chem. 2012; 19: 2611-20.
25. D'Cruz LG, Baboonian C, Phillimore HE et al. Cytosine methylation confers instability on the cardiac troponin T gene in hypertrophic cardiomyopathy. J. Med. Genet. 2000; 37: E18.
26. Gaikwad AB, Sayyed SG, Lichtnekert J, Tikoo K, Anders HJ. Renal failure increases cardiac histone H3 acetylation, dimethylation, and phosphorylation and the induction of cardiomyopathy-related genes in type 2 diabetes. Am. J. Pathol. 2010; 176: 1079-83.
27. Monkemann H, De Vriese AS, Blom HJ et al. Early molecular events in the development of the diabetic cardiomyopathy. Amino Acids 2002; 23: 331-6.
28. Movassagh M, Choy MK, Goddard M, Bennett MR, Down TA, Foo RS. Differential DNA methylation correlates with differential expression of angiogenic factors in human heart failure. PLoS ONE 2010; 5: e8564.
29. Nicholson TB, Chen T, Richard S. The physiological and pathophysiological role of PRMT1-mediated protein arginine methylation. Pharmacol. Res. 2009; 60: 466-74.
30. Denda A, Kitayama W, Kishida H et al. Development of hepatocellular adenomas and carcinomas associated with fibrosis in C57BL/6J male mice given a choline-deficient, l-amino acid-defined diet. Jpn. J. Cancer Res. 2002; 93: 125-32.
31. Hill-Baskin AE, Markiewski MM, Buchner DA et al. Diet-induced hepatocellular carcinoma in genetically predisposed mice. Hum. Mol. Genet. 2009; 18: 2975-88.
32. Wang B, Majumder S, Nuovo G et al. Role of microRNA-155 at early stages of hepatocarcinogenesis induced by choline-deficient and amino acid-defined diet in C57BL/6 mice. Hepatology 2009; 50: 1152-61.
33. Ren J, Privratsky JR, Yang X, Dong F, Carlson EC. Metallothionein alleviates glutathione depletion-induced oxidative cardiomyopathy in murine hearts. Crit. Care Med. 2008; 36: 2106-16.
34. Cai L, Wang Y, Zhou G et al. Attenuation by metallothionein of early cardiac cell death via suppression of mitochondrial oxidative stress results in a prevention of diabetic cardiomyopathy. J. Am. Coll. Cardiol. 2006; 48: 1688-97.
35. Zhou G, Li X, Hein DW et al. Metallothionein suppresses angiotensin II-induced nicotinamide adenine dinucleotide phosphate oxidase activation, nitrosative stress, apoptosis, and pathological remodeling in the diabetic heart. J. Am. Coll. Cardiol. 2008; 52: 655-66.
36. Cai L, Wang J, Li Y et al. Inhibition of superoxide generation and associated nitrosative damage is involved in metallothionein prevention of diabetic cardiomyopathy. Diabetes 2005; 54: 1829-37.
37. Inglot P, Lewinska A, Potocki L et al. Cadmium-induced changes in genomic DNA-methylation status increase aneuploidy events in a pig Robertsonian translocation model. Mutat. Res. 2012; 747: 182-9.
38. Beltran-Alvarez P, Pagans S, Brugada R. The cardiac sodium channel is post-translationally modified by arginine methylation. J. Proteome Res. 2011; 10: 3712-9.
39. Kao YH, Chen YC, Chung CC et al. Heart failure and angiotensin II modulate atrial Pitx2c promotor methylation. Clin. Exp. Pharmacol. Physiol. 2013; 40: 379-84.
40. Pandya K, Kohro T, Mimura I et al. Distribution of histone3 lysine 4 trimethylation at T3-responsive loci in the heart during reversible changes in gene expression. Gene Expr. 2012; 15: 183-98.
41. Movassagh M, Vujic A, Foo R. Genome-wide DNA methylation in human heart failure. Epigenomics 2011; 3: 103-9.
42. Haddad F, Jiang W, Bodell PW, Qin AX, Baldwin KM. Cardiac myosin heavy chain gene regulation by thyroid hormone involves altered histone modifications. Am. J. Physiol. Heart Circ. Physiol. 2010; 299: H1968-80.
43. Gluckman PD, Hanson MA, Buklijas T, Low FM, Beedle AS. Epigenetic mechanisms that underpin metabolic and cardiovascular diseases. Nat. Rev. Endocrinol. 2009; 5: 401-8.
44. 2+-ATPase and calcium homeostasis in cardiac myocytes. Lab. Invest. 2011; 91: 1291-7.
45. Messner B, Ploner C, Laufer G, Bernhard D. Cadmium activates a programmed, lysosomal membrane permeabilization-dependent necrosis pathway. Toxicol. Lett. 2012; 212: 268-75.
46. Knoflach M, Messner B, Shen YH et al. Non-toxic cadmium concentrations induce vascular inflammation and promote atherosclerosis. Circ. J. 2011; 75: 2491-5.
47. Yazihan N, Kocak MK, Akcil E, Erdem O, Sayal A. Role of midkine in cadmium-induced liver, heart and kidney damage. Hum. Exp. Toxicol. 2011; 30: 391-7.
48. Houston MC. The role of mercury and cadmium heavy metals in vascular disease, hypertension, coronary heart disease, and myocardial infarction. Altern. Ther. Health Med. 2007; 13: S128-33.